These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32936357)

  • 1. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
    Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
    Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.
    Leonardi L; Di Pietro G; Di Pasquale A; Vanoli F; Fionda L; Garibaldi M; Galosi E; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 May; 43(5):3387-3394. PubMed ID: 34802089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy.
    Tan CY; Yahya MA; Goh KJ; Shahrizaila N
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109705
    [No Abstract]   [Full Text] [Related]  

  • 5. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
    Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
    Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
    Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
    Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
    Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
    Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy.
    Hodel J; Benadjaoud S; Benadjaoud MA; Lefaucheur JP; Planté-Bordeneuve V
    Eur Radiol; 2022 Nov; 32(11):7865-7871. PubMed ID: 35438324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.
    Gasparotti R; Salvalaggio A; Corbo D; Agazzi G; Cacciavillani M; Lozza A; Fenu S; De Vigili G; Tagliapietra M; Fabrizi GM; Pareyson D; Obici L; Briani C
    J Neurol; 2023 Oct; 270(10):4827-4840. PubMed ID: 37329346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
    Ohashi N; Kodaira M; Morita H; Sekijima Y
    Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
    Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
    J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
    Fortanier E; Delmont E; Verschueren A; Attarian S
    Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
    Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
    Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.
    Tan CY; Arumugam T; Razali SNO; Yahya MA; Goh KJ; Shahrizaila N
    J Clin Neurosci; 2018 Nov; 57():198-201. PubMed ID: 30145079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy correlates to nerve damage in p.A117S late-onset transthyretin amyloid polyneuropathy.
    Lin YH; Hsueh HW; Su MY; Cheng MF; Chiang MC; Juang JJ; Kao YH; Chang KC; Feng FP; Hsieh ST; Chao CC
    Ann Clin Transl Neurol; 2022 Sep; 9(9):1359-1369. PubMed ID: 35945697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.